Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !
Saregama India Zukünftiges Wachstum
Future Kriterienprüfungen 3/6
Saregama India wird ein jährliches Gewinn- und Umsatzwachstum von 16.3% bzw. 21.4% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 18.5% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 16.2% betragen.
Wichtige Informationen
16.9%
Wachstumsrate der Gewinne
16.8%
EPS-Wachstumsrate
| Entertainment Gewinnwachstum | 19.9% |
| Wachstumsrate der Einnahmen | 19.8% |
| Zukünftige Eigenkapitalrendite | 16.9% |
| Analystenabdeckung | Low |
| Zuletzt aktualisiert | 27 May 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Saregama India Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Feb 13
Saregama India Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Jan 25Recent updates
Optimistic Investors Push Saregama India Limited (NSE:SAREGAMA) Shares Up 27% But Growth Is Lacking
Apr 27Is It Time To Consider Buying Saregama India Limited (NSE:SAREGAMA)?
Mar 28What Saregama India Limited's (NSE:SAREGAMA) P/E Is Not Telling You
Mar 06Saregama India Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Feb 13Returns At Saregama India (NSE:SAREGAMA) Are On The Way Up
Dec 23Is Saregama India Limited (NSE:SAREGAMA) Potentially Undervalued?
Nov 18Saregama India (NSE:SAREGAMA) Is Doing The Right Things To Multiply Its Share Price
Sep 22Should You Think About Buying Saregama India Limited (NSE:SAREGAMA) Now?
Jun 17If EPS Growth Is Important To You, Saregama India (NSE:SAREGAMA) Presents An Opportunity
Feb 18Saregama India Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Jan 25Returns At Saregama India (NSE:SAREGAMA) Are On The Way Up
Dec 29Does Saregama India (NSE:SAREGAMA) Deserve A Spot On Your Watchlist?
Sep 17Saregama India (NSE:SAREGAMA) Is Doing The Right Things To Multiply Its Share Price
Jul 06Should You Investigate Saregama India Limited (NSE:SAREGAMA) At ₹394?
May 27If You Like EPS Growth Then Check Out Saregama India (NSE:SAREGAMA) Before It's Too Late
Apr 21Saregama India (NSE:SAREGAMA) Is Experiencing Growth In Returns On Capital
Apr 01Should You Be Adding Saregama India (NSE:SAREGAMA) To Your Watchlist Today?
Dec 28At ₹4,639, Is Saregama India Limited (NSE:SAREGAMA) Worth Looking At Closely?
Nov 11Do Saregama India's (NSE:SAREGAMA) Earnings Warrant Your Attention?
Sep 21Why We Like The Returns At Saregama India (NSE:SAREGAMA)
Aug 21Is Now The Time To Put Saregama India (NSE:SAREGAMA) On Your Watchlist?
May 31Are You An Income Investor? Don't Miss Out On Saregama India Limited (NSE:SAREGAMA)
Apr 20Saregama India (NSE:SAREGAMA): Are Investors Overlooking Returns On Capital?
Mar 17Are Strong Financial Prospects The Force That Is Driving The Momentum In Saregama India Limited's NSE:SAREGAMA) Stock?
Feb 23Is Now An Opportune Moment To Examine Saregama India Limited (NSE:SAREGAMA)?
Feb 10Here's Why We Think Saregama India (NSE:SAREGAMA) Is Well Worth Watching
Jan 28Update: Saregama India (NSE:SAREGAMA) Stock Gained 61% In The Last Year
Oct 20Saregama India Limited (NSE:SAREGAMA) Has Got What It Takes To Be An Attractive Dividend Stock
Sep 29
A Look At The Fair Value Of Saregama India Limited (NSE:SAREGAMA)
Sep 08Is Saregama India Limited (NSE:SAREGAMA) Potentially Undervalued?
Aug 19Should You Buy Saregama India Limited (NSE:SAREGAMA) For Its Upcoming Dividend?
Jul 31What Do The Returns At Saregama India (NSE:SAREGAMA) Mean Going Forward?
Jul 27Are Strong Financial Prospects The Force That Is Driving The Momentum In Saregama India Limited's NSE:SAREGAMA) Stock?
Jul 10Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 3/31/2027 | 13,977 | 3,153 | 1,387 | N/A | 1 |
| 3/31/2026 | 12,390 | 2,785 | 460 | N/A | 3 |
| 3/31/2025 | 10,390 | 2,224 | -389 | N/A | 4 |
| 3/31/2024 | 8,270 | 1,927 | 213 | N/A | 4 |
| 12/31/2023 | 7,436 | 1,875 | N/A | N/A | N/A |
| 9/30/2023 | 7,213 | 1,885 | -618 | 329 | N/A |
| 6/30/2023 | 7,339 | 1,870 | N/A | N/A | N/A |
| 3/31/2023 | 7,366 | 1,853 | -97 | 934 | N/A |
| 12/31/2022 | 7,242 | 1,882 | 199 | 1,539 | N/A |
| 9/30/2022 | 6,890 | 1,791 | 776 | 1,773 | N/A |
| 6/30/2022 | 6,450 | 1,668 | -39 | 779 | N/A |
| 3/31/2022 | 5,762 | 1,644 | 217 | 944 | N/A |
| 12/31/2021 | 5,238 | 1,414 | 626 | 973 | N/A |
| 9/30/2021 | 5,074 | 1,296 | 892 | 1,235 | N/A |
| 6/30/2021 | 4,704 | 1,240 | N/A | N/A | N/A |
| 3/31/2021 | 4,420 | 1,126 | 1,677 | 1,897 | N/A |
| 12/31/2020 | 4,272 | 913 | N/A | N/A | N/A |
| 9/30/2020 | 4,227 | 699 | 1,338 | 1,433 | N/A |
| 6/30/2020 | 4,721 | 610 | N/A | N/A | N/A |
| 3/31/2020 | 5,215 | 439 | 711 | 793 | N/A |
| 12/31/2019 | 5,396 | 451 | N/A | N/A | N/A |
| 9/30/2019 | 5,673 | 482 | 128 | 165 | N/A |
| 6/30/2019 | 5,539 | 443 | N/A | N/A | N/A |
| 3/31/2019 | 5,447 | 541 | -478 | -357 | N/A |
| 3/31/2018 | 3,566 | 285 | -216 | -190 | N/A |
| 3/31/2017 | 2,185 | 84 | N/A | -36 | N/A |
| 3/31/2016 | 2,217 | 68 | N/A | 319 | N/A |
| 3/31/2015 | 1,865 | 68 | N/A | 27 | N/A |
| 3/31/2014 | 1,775 | 189 | N/A | 274 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: SAREGAMADas prognostizierte Gewinnwachstum (16.3% pro Jahr) liegt über der Sparquote (6.7%).
Ertrag vs. Markt: SAREGAMADie Erträge des Unternehmens (16.9% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Indian (16% pro Jahr).
Hohe Wachstumserträge: SAREGAMADie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.
Einnahmen vs. Markt: SAREGAMADie Einnahmen des Unternehmens (21.4% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Indian (9.4% pro Jahr).
Hohe Wachstumseinnahmen: SAREGAMADie Einnahmen des Unternehmens (19.8% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: SAREGAMADie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (16.2 %).